University of Tasmania
Browse

File(s) under permanent embargo

Which is the safest NSAID for patients at elevated cardiovascular risk?

journal contribution
posted on 2023-05-21, 20:18 authored by Luke BereznickiLuke Bereznicki, Shane JacksonShane Jackson, Gregory PetersonGregory Peterson
The issue of the cardiovascular risk associated with non-steroidal antiinflammatory drugs (NSAIDs) intensified recenty with the release of a systematic review of observational studies questioning the safety of diclofenac, a non-selective NSAID. In fact, this review demonstrated an increased cardiovascular risk for rofecoxib, diclofenac, meloxicam and indomethacin; a neutral effect was shown with celecoxib, naproxen and ibuprofen (although the lower bound of the 95% confidence interval for the latter approached, which is less than reassuring). Observational studies are limited in that they are generally based on the prescription of drugs via health care providers; this makes it difficult to discern what dosages have actually been taken, and whether subjects have used over-the-counter NSAIDs or concomitant low-dose aspirin.

History

Publication title

Australian Pharmacist

Volume

25

Issue

11

Pagination

853

ISSN

0728-4632

Department/School

School of Pharmacy and Pharmacology

Publisher

Pharmaceutical Society of Australia

Place of publication

Canberra, Australia

Repository Status

  • Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC